BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21473139)

  • 1. [Expression and clinical significance of human nuclear distribution C in nasopharyngeal carcinoma].
    Chen Y; Yang Y; Lin Z; Peng H; Lu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):71-3. PubMed ID: 21473139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG; Xiang XJ; He YJ
    Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
    Cui D; Zhang X; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and clinical significance of vascular endothelial growth factor in nasopharyngeal carcinoma].
    Zhao SP; Wang CL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):114-6. PubMed ID: 12934350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression clinical significance of nm23-H1 and vessel endothelium growth factor protein in nasopharyngeal carcinoma].
    Jiang WZ; Liao YP; Zhao SP; Wu HJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Mar; 41(3):200-4. PubMed ID: 16759016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of DNA-PKcs in nasopharyngeal carcinoma].
    Yan SS; Liu L; Liu ZG; Zeng MS; Song LB; Xia YF
    Ai Zheng; 2008 Sep; 27(9):979-83. PubMed ID: 18799040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis].
    Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma].
    Wang M; Li JT; Zeng YX; Hou JH; Lin QQ
    Ai Zheng; 2005 Oct; 24(10):1230-4. PubMed ID: 16219138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
    Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
    Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].
    Mai HQ; Zeng ZY; Zhang HZ; Hou JH; Mo HY; Guo X; Min HQ; Hong MH
    Ai Zheng; 2005 May; 24(5):611-5. PubMed ID: 15890108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of E-cadherin in nasopharyngeal carcinoma and its relationship with cervical lymph node metastasis].
    Liu Q; Wang YD; Jing SH; Wang XL; Cheng YJ; Wu FP
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):425-8. PubMed ID: 20819482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma].
    Zhang S; Yang JH; Cai PC
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3131-4. PubMed ID: 19159596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
    Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
    Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of DeltaNp63 protein in nasopharyngeal carcinoma and its significance].
    Liao ZL; Deng ZL; Zhang B; Xie KS
    Ai Zheng; 2004 Mar; 23(3):288-91. PubMed ID: 15025959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Wei J; Huang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of tissue inhibitor of metalloproteinase-2 in nasopharyngeal carcinoma].
    Yao L; Liu P; Lu X; Liu F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(18):831-3. PubMed ID: 21254651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.